参考文献
1: Hahn SS, Tang Q, Zheng F, Zhao S, Wu J. GW1929 inhibits α7 nAChR expression
through PPARγ-independent activation of p38 MAPK and inactivation of PI3-K/mTOR:
The role of Egr-1. Cell Signal. 2014 Apr;26(4):730-9. doi:
10.1016/j.cellsig.2013.12.019. Epub 2014 Jan 8. PubMed PMID: 24412748.
2: Wojtowicz AK, Szychowski KA, Kajta M. PPAR-γ agonist GW1929 but not antagonist
GW9662 reduces TBBPA-induced neurotoxicity in primary neocortical cells. Neurotox
Res. 2014 Apr;25(3):311-22. doi: 10.1007/s12640-013-9434-z. Epub 2013 Oct 17.
PubMed PMID: 24132472; PubMed Central PMCID: PMC3936120.
3: Kaundal RK, Sharma SS. Ameliorative effects of GW1929, a nonthiazolidinedione
PPARγ agonist, on inflammation and apoptosis in focal cerebral
ischemic-reperfusion injury. Curr Neurovasc Res. 2011 Aug 1;8(3):236-45. PubMed
PMID: 21722092.
4: Kaundal RK, Sharma SS. GW1929: a nonthiazolidinedione PPARγ agonist,
ameliorates neurological damage in global cerebral ischemic-reperfusion injury
through reduction in inflammation and DNA fragmentation. Behav Brain Res. 2011
Jan 20;216(2):606-12. doi: 10.1016/j.bbr.2010.09.001. Epub 2010 Sep 15. PubMed
PMID: 20833208.
5: Moore-Carrasco R, Figueras M, Ametller E, López-Soriano FJ, Argilés JM,
Busquets S. Effects of the PPARgamma agonist GW1929 on muscle wasting in
tumour-bearing mice. Oncol Rep. 2008 Jan;19(1):253-6. PubMed PMID: 18097603.
6: Huang WC, Chio CC, Chi KH, Wu HM, Lin WW. Superoxide anion-dependent
Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma
agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. Exp
Cell Res. 2002 Jul 15;277(2):192-200. PubMed PMID: 12083801.
